Travaux scientifiques

Prof. Dr. Erkan Doğan

49 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil

  1. Adem Yokuş, Harun Arslan, Zülküf Akdemir, İbrahim Akbudak, Necat Almalı, Çetin Kotan, Erkan Doğan. Measurement of Postoperative Liver Volume Changes In Patients With Gastric Cancer By Computed Tomography. East J Med 28(2):206-210, 2023. DOI:10.5505/ejm.2023.12129

    Source : page de profil sur medicana.com.tr

  2. Aycan A, Celik S, Kuyumcu F, Akyol ME, Arslan M, Dogan E, Arslan H. Spinal Metastasis of Unknown Primary Accompanied by Neurologic Deficit or Vertebral Instability. World Neurosurg. 2018 Jan;109:e33-e42. doi:10.1016/j.wneu.2017.09.099

    Source : page de profil sur medicana.com.tr

  3. Arslan H, Fatih Özbay M, Çallı İ, Doğan E, Çelik S, Batur A, Bora A, Yavuz A, Bulut MD, Özgökçe M, Çetin Kotan M. Contribution of diffusion weighted MRI to diagnosis and staging in gastric tumors and comparison with multi-detector computed tomography. Radiol Oncol. 2017;51(1):23-29

    Source : page de profil sur medicana.com.tr

  4. Sunnetcioglu A, Arısoy A, Demir Y, Ekin S, Dogan E. Associations between the standardized uptake value of 18F-FDG PET/CT and demographic, clinical, pathological, radiological factors in lung cancer. Int J Clin Exp Med. 2015;8(9):15794-800

    Source : page de profil sur medicana.com.tr

  5. Turan N, Benekli M, Unal OU, Unek İT, Tastekin D ve ark. Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma. Chin J Cancer Res. 2015;27(4):408-16

    Source : page de profil sur medicana.com.tr

  6. Can A, Dogan E, Bayoglu IV ve ark. Multicenter epidemiologic study on hepatocellular carcinoma in Turkey. Asian Pac J Cancer Prev. 2014;15(6):2923-7

    Source : page de profil sur medicana.com.tr

  7. Turan N, Benekli M, Dane F ve ark. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer. Thorac Cancer. 2014;5(5):398-404

    Source : page de profil sur medicana.com.tr

  8. Koca D, Dogan E, Yardim H ve ark. A modified DCF regimen as primary treatment for patients with metastatic gastric cancer. J BUON. 2013;18(2):377-84

    Source : page de profil sur medicana.com.tr

  9. Dogan E, Yorgun H, Petekkaya I ve ark. Evaluation of cardiac safety of lapatinib therapy for ErbB2-positive metastatic breast cancer: A single center experience. Med Oncol. 2012

    Source : page de profil sur medicana.com.tr

  10. Dogan E, Yalcin S, Koca D, Olmez A. Clinicopathological characteristics of hepatocellular carcinoma in Turkey. Asian Pac J Cancer Prev. 2012;13:2985-90

    Source : page de profil sur medicana.com.tr

  11. Arslan C, Ozdemir E, Dogan E, Ozisik Y, Altundag K. Secondary hematological malignancies after treatment of non-metastatic breast cancer. J BUON. 2011;16:744-50

    Source : page de profil sur medicana.com.tr

  12. Dogan E, Aksoy S, Dizdar O ve ark. Pure mucinous carcinoma of the breast: a single center experience. J BUON. 2011;16:565-7

    Source : page de profil sur medicana.com.tr

  13. Bulut N, Aksoy S, Dizdar O ve ark. Demographic and clinico-pathological characteristics in patients with triple-negative and non-triple-negative breast cancer. Med Oncol. 2011;28:S75-9

    Source : page de profil sur medicana.com.tr

  14. Turgut D, Kalan I, Dede DS, Dogan E, Altundag K. Ipsilateral axillary recurrence of breast cancer 22 years after primary surgery: the latest recurrence in the literature. J BUON. 2011;16:571

    Source : page de profil sur medicana.com.tr

  15. Kara O, Ozdemir E, Arslan C, Dogan E, Altundag K. Acute promyelocytic leukemia in a young patient with breast cancer. Med Oncol. 2011;28:249-50

    Source : page de profil sur medicana.com.tr

  16. Z. Arik, E. Dogan, S. Aksoy, K. Altundag. Long-term survivors among breast cancer patients with brain metastases. Ann Oncol. 2010;21:1128

    Source : page de profil sur medicana.com.tr

  17. E. Dogan, S. Aksoy, O. Dizdar, D.S. Dede, C. Arslan, Y. Ozisik, K. Altundag. Other malignancies in patients with breast cancer: a single institute experience. Med Oncol. 2010 Dec;27(4):1434-1435

    Source : page de profil sur medicana.com.tr

  18. E. Dogan, S. Aksoy, C. Arslan, D.S. Dede, K. Altundag. Probable sorafenib-induced reversible encephalopathy in a patient with hepatocellular carcinoma. Med Oncol. 2010;27:1436-1437

    Source : page de profil sur medicana.com.tr

  19. E. Altan, C. Arslan, D. Dede, E. Dogan, K. Altundag. Primary angiosarcoma of the breast after pregnancy. Am Surg. 2010;76:E115

    Source : page de profil sur medicana.com.tr

  20. N. Kertmen, E. Dogan, K. Altundag. Pure mucinous breast carcinoma with lung metastasis in a young male patient. Am Surg. 2010;76:E146

    Source : page de profil sur medicana.com.tr

  21. D. Sarikaya, O. Varan, G. Ozen, E. Dogan, K. Altundag. Late recurrence of granulosa cell tumor of the ovary with synchronous gastric signet-ring cell carcinoma. J BUON. 2010;15:799-800

    Source : page de profil sur medicana.com.tr

  22. O. Varan, G. Ozen, D. Sarikaya, E. Dogan, K. Altundag. Malignant hypercalcemia in a patient with maxillary sinus squamous cell carcinoma without skeletal metastases. Am Surg. 2010;76:E9-10

    Source : page de profil sur medicana.com.tr

  23. E. Altan, B. Bitik, Y. Kalpakci, E. Dogan, K. Altundag. Probable hepatotoxicity related to Nerium oleander extract in a patient with metastatic synovial sarcoma of the knee. J Altern Complement Med. 2009;15:113

    Source : page de profil sur medicana.com.tr

  24. B. Bitik, Y. Kalpakci, E. Altan, E. Dogan, K. Altundag. Successful treatment of primary duodenal carcinoma with bilateral adrenal metastases with docetaxel-cisplatin-5-fluorouracil regimen. Ann Oncol. 2009;20:394-395

    Source : page de profil sur medicana.com.tr

  25. E. Dogan, R. Ozgur, V. Ercan, A. Tekin, O. Senkal, U. Cevikbas. Nodular regenerative hyperplasia of the liver: a case report. Turkish Journal of Gastroenterology. 2003;14:64

    Source : page de profil sur medicana.com.tr

  26. E. Dogan, H. Yorgun, I. Petekkaya, N. Ozer, K. Altundag, Y. Ozisik. Evaluation of cardiac safety of lapatinib therapy for ErbB2-positive metastatic breast cancer: A single center experience. 2011 ASCO Annual Meeting, April 2011, Chicago, USA. Sözel Bildiri

    Source : page de profil sur medicana.com.tr

  27. O. Keskin, C. Arslan, O. Dizdar, S. Aksoy, E. Dogan, D.S. Dede, I.H. Gullu, Y.Y. Ozisik, K. Altundag. Relation of tumor localization and metastasis sites in patients with breast cancer. ASCO 2011, Chicago, USA

    Source : page de profil sur medicana.com.tr

  28. D.S. Dede, C. Arslan, S. Aksoy, O. Dizdar, E. Dogan, A. Alkan, I.H. Gullu, Y.Y. Ozisik, K. Altundag. Clinicopathologic features of patients with breast cancer under treatment of bisphosphonate at the time of diagnosis: Retrospective analysis. ASCO 2011, Chicago, USA

    Source : page de profil sur medicana.com.tr

  29. I. Petekkaya, C. Arslan, E. Dogan, M. Solak, O. Keskin, N. Kertmen, Y.Y. Ozisik, K. Altundag. Body mass index in breast cancer subtypes. ASCO 2011, Chicago, USA

    Source : page de profil sur medicana.com.tr

  30. M. Solak, F.P. Turkoz, I. Petekkaya, C. Arslan, N. Kertmen, O. Keskin, E. Dogan, Y.Y. Ozisik, M.K. Altundag. Association between blood groups and breast cancer subtype. ASCO 2011, Chicago, USA

    Source : page de profil sur medicana.com.tr

  31. M. Ozen, S. Aksoy, O. Dizdar, D.S. Dede, E. Dogan, C. Arslan, I.H. Gullu, M.K. Altundag. Addition of nine weeks of trastuzumab to adjuvant chemotherapy in operable HER2-positive breast cancer patients: Retrospective analysis. ASCO 2010, Chicago, USA

    Source : page de profil sur medicana.com.tr

  32. Z.G. Sürmeli, S. Aksoy, O. Dizdar, D.S. Dede, E. Dogan, C. Arslan, I.H. Gullu, K. Altundag. Docetaxel/doxorubicin/cyclophosphamide chemotherapy for operable HER2-negative, node-positive breast cancer patients: Results from a single institution. ASCO 2010, Chicago, USA

    Source : page de profil sur medicana.com.tr

  33. S. Aksoy, C. Arslan, M. Kurt, O. Dizdar, D.S. Dede, E. Dogan, I.H. Gullu, Y.Y. Ozisik, M.K. Guler. Increased mean corpuscular volume of erythrocytes with capecitabine treatment in metastatic breast cancer patients: A marker of clinical benefit. ASCO 2010, Chicago, USA

    Source : page de profil sur medicana.com.tr

  34. C. Arslan, O. Dizdar, D.S. Dede, M. Isik, E. Dogan, Y.Y. Ozisik, K. Altundag. Clinicopathological features of locally advanced HER2-negative breast cancer patients with stage N3 disease. ASCO 2011, Chicago, USA

    Source : page de profil sur medicana.com.tr

  35. S. Aksoy, N. Bulut, O. Dizdar, D. Dede, C. Arslan, E. Dogan, Y. Ozisik, K. Altundag. Demographic, clinical and pathological characteristics of very young breast cancer patients younger than 30 years in Turkish population. 5th International APOCP Conference, 2010, Istanbul, Turkey

    Source : page de profil sur medicana.com.tr

  36. A. Can, E. Dogan, I.V. Bayoglu, A.M. Tatli, M. Besiroglu, M. Kocer, U. Uyetürk, D. Kivrak, Z. Orakci, O. Bal, T. Kacan, N. Turan. Epidemiology of Hepatocellular Carcinoma in Turkey: Outcome of a Multicenter Study. 3rd International Gastrointestinal Cancer Conference, December 13-15, 2013, Antalya, Turkey

    Source : page de profil sur medicana.com.tr

  37. E. Dogan, A. Can, M.F. Ozbay, H. Arslan, G. Yilmazer, D. Koca, C. Kotan. Clinicopathological Characteristics of Esophageal Cancer Patients of Van Region. 3rd International Gastrointestinal Cancer Conference, December 13-15, 2013, Antalya, Turkey

    Source : page de profil sur medicana.com.tr

  38. H. Arslan, M.F. Ozbay, I. Calli, E. Dogan. Comparison of Diffusion Weighted MR Imaging with Multidetector CT Imaging in the Diagnosis of Gastric Tumors. 3rd International Gastrointestinal Cancer Conference, December 13-15, 2013, Antalya, Turkey

    Source : page de profil sur medicana.com.tr

  39. E. Dogan, H. Guducuoglu, A. Can, R. Erten, S. Koc, Y. Bayram. Human Papilloma Virus and Survival of Patients with Esophageal Squamous Cell Cancers. 3rd International Gastrointestinal Cancer Conference, December 13-15, 2013, Antalya, Turkey

    Source : page de profil sur medicana.com.tr

  40. H.G. Sahin, G. Guvendi, H.A. Sahin, D. Kusaslan Avci, E. Dogan. Violence among Cancer Patients in Eastern Turkey. World Congress of Internal Medicine, October 25-29, 2014, Seoul, Korea. Oral Presentation

    Source : page de profil sur medicana.com.tr

  41. E. Dogan, A. Can. Comparison of palliative chemotherapy using cisplatin and fluorouracil with docetaxel, cisplatin and fluorouracil combination regimens in patients with metastatic esophageal cancer. 4th International Gastrointestinal Cancer Conference, December 2014. Oral Presentation

    Source : page de profil sur medicana.com.tr

  42. S. Celik, E. Dogan, H. Arslan, A. Batur, R. Kiziltan, O. Toktas, O. Yilmaz, M.C. Kotan. Changing Trends and Experience with Esophageal Cancer Surgery in a Single University Hospital: Are the Results Similar or Not. Bagcilar Medical Bulletin. 2017;2(1):1-8

    Source : page de profil sur medicana.com.tr

  43. E. Dogan. Nonseminomatous Testicular Cancer. Turkiye Klinikleri Journal of Medical Oncology. 2015

    Source : page de profil sur medicana.com.tr

  44. G. Ugurluer, E. Dogan, N. Turan. Cutaneous Metastases from Transitional Cell Carcinoma of the Bladder in a Case with Two Primaries. Erciyes Medical Journal. 2010

    Source : page de profil sur medicana.com.tr

  45. E. Dogan, S. Kilickap, I. Celik. New Drugs Used in Chemoprevention. Review. Turkiye Klinikleri Journal of Medical Oncology Special Topics. 2009;73-82

    Source : page de profil sur medicana.com.tr

  46. A. Surardamar, T. Yakar, N. Usalan, E. Dogan, M.F. Akdogan, O. Yapici. Conn’s Syndrome: Case Report. Haydarpasa Numune Training and Research Hospital Medical Journal. 2003;115-118

    Source : page de profil sur medicana.com.tr

  47. E. Hur, N.Y. Bagatur, E. Ahishali, E. Dogan, O. Mavis. Comparison of Treatment Efficacy of Two-Week Lansoprazole plus One- and Two-Week Clarithromycin Combinations in Helicobacter Pylori Eradication. Taksim Training and Research Hospital Medical Journal. 2002;32:7-12

    Source : page de profil sur medicana.com.tr

  48. E. Hur, O. Mavis, E. Dogan, F. Akvardar, R. Ozgur, V. Ercan. Monoclonal Gammopathy of Undetermined Significance: A Case Report. Taksim Training and Research Hospital Medical Journal. 2002;32:13-16

    Source : page de profil sur medicana.com.tr

  49. E. Dogan, I. Ekizoglu, E. Hur, O. Mavis, V. Ercan, A. Tekin. Phenytoin-Induced Osteomalacia: A Case Report. Taksim Training and Research Hospital Medical Journal. 2002;32:20-22

    Source : page de profil sur medicana.com.tr